Neurlogic clinical trial - UCB MG0007

Status:

Start-Up

An Open-label Extension study to Evaluate Rozanolixizumab in Study Participants with Generalized Myasthenia Gravis

Drug

Rozanolixizumab

Condition

Generalized Myasthenia Gravis Myasthenia Gravis

Keywords

Rozanolixizumab | Myasthenia Gravis | UCB